+ All Categories
Home > Documents > PHARMA TEAM 428

PHARMA TEAM 428

Date post: 09-Feb-2016
Category:
Upload: xaria
View: 26 times
Download: 0 times
Share this document with a friend
Description:
PHARMA TEAM 428. ANTIBIOTICS(4). MACROLIDES. cont’d. Mechanism of action: Irreversibly inhibit protein synthesis by binding to the 50S subunit Antibacterial activity: Bactericidal or bacteriostatic , depending on the concentration and type of bacteria. Cont’d. Erythromycin : - PowerPoint PPT Presentation
Popular Tags:
37
PHARMA TEAM 428 ANTIBIOTICS(4) Pharma Team 428
Transcript
Page 1: PHARMA TEAM 428

Pharma Team 428

PHARMA TEAM 428ANTIBIOTICS(4)

Page 2: PHARMA TEAM 428

Pharma Team 428

MACROLIDES

MACROLIDES

Erythromycin Clarithromycin Azithromycin

Page 3: PHARMA TEAM 428

Pharma Team 428

cont’d

• Mechanism of action:• Irreversibly inhibit protein

synthesis by binding to the 50S subunit

• Antibacterial activity:• Bactericidal or bacteriostatic,

depending on the concentration and type of bacteria.

Page 4: PHARMA TEAM 428

Pharma Team 428

Page 5: PHARMA TEAM 428

Pharma Team 428

Cont’d

• Erythromycin:1. Most important one. 2. Not acid stable (acid labile).3. Irritating to GI.4. Short t1/2 , 4 doses per day.5. Works more or less like

penicillin G, mainly against G +ve bacteria.

Page 6: PHARMA TEAM 428

Pharma Team 428

Clinical usage

L. Pneumop

hila M.

pneumoniae

Chlamydia species

Intracellular pathogens

Page 7: PHARMA TEAM 428

Pharma Team 428

Cont’d

Clarithromycin:PK:1. Acid stable.2. Food delays absorption but doesn’t

alter its extent.3. Metabolized by the liver to active

metabolite 14- hydroxy clarithro.4. Broad spectrum.5. Widely distributed, except brain

and CSF6. Protein binding 40 – 70 %

Page 8: PHARMA TEAM 428

Pharma Team 428

Both erythromycin and clarithromycin inhibit cytochrome P450 enzymes

Cont’d

7 . Excretion: • Excreted in urine – unchanged (20

– 40 %)• 14- H. clarithromycin (10 – 15

%) by biliary 8 . Half-life clarithromycin 3 – 7

hr 14 – H. clarithromycin 5- 9

hr

Page 9: PHARMA TEAM 428

Pharma Team 428

Cont’d• Advantages over

erythromycin:1. Lower frequency of GI intolerance2. Less frequent dosing ( twice

daily )

Page 10: PHARMA TEAM 428

Pharma Team 428

Clinical usage Staph. Aureus

S. Pneumoniae

S. Pyogens

C. diphtheria

G +ve H. Pylori

M. catarrhalis

H. influenzae

G –ve

Page 11: PHARMA TEAM 428

Pharma Team 428

Cont’d

L. Pneumophila

M. pneumoniae

Intracellular organisms

Indications:1. Pharyngitis

/ tonsilitis, Otitis media,& sinusitis.

2. Pneumonia3. Diphtheria4. Legionnair

es disease5. Adjunct in

treatment of duodenal ulcer ( H. pylori)

Page 12: PHARMA TEAM 428

Pharma Team 428

Cont’d• Azithromycin

• PK:1. Rapidly absorbed from GI2. Food delays its absorption3. Widely distributed (extensive tissue

distribution), except to the CSF4. Protein binding 51%5. Doesn’t undergo significant hepatic

metabolism6. Mainly active against G-ve bacteria but

less effective against G+ve (S.pneumoniae & S.pyogenes) than erythromycin

Page 13: PHARMA TEAM 428

Pharma Team 428

Cont’d

7. Biliary route is the major route of elimination

8. Only 10-15% excreted unchanged in the urine

9. Half- life approx 3 days

• Advantage over erythromycin & clarithromycin:

1. Once daily dosing.2. No inhibition of cytochrome P450, in other

word, doesn’t affect metabolism of another drugs.

Page 14: PHARMA TEAM 428

Pharma Team 428

Clinical usage

Staph. Aureus

S. Pyogens

S. Pneumon

iae

G +ve H.

influenzae

M. catarrhali

s

G –ve

Page 15: PHARMA TEAM 428

Pharma Team 428

Cont’dIndications for azithromycin:1. Pharyngitis/

tonsilitis(S.pyogens), otitis, sinusitis (Staph aureus & H. influenzae)

2. Legionnaires’ disease drug of choice

3. Pneumonia(M. pneumoniae)4. Uncomplicated genital

chlamydial infections

5. Acne

Page 16: PHARMA TEAM 428

Pharma Team 428

Cont’d

• Drugs used to treat acne: 1. Clindamycin topically2. Azithromycin capsules3. Tetracyclins.

Page 17: PHARMA TEAM 428

Pharma Team 428

Cont’d

Side effects of macrolides:1. Nausea, vomiting, abdominal pain

& diarrhea(antibiotic-associated colitis)

2. Allergic reactions- urticaria, mild skin rashes

3. Sore mouth

Page 18: PHARMA TEAM 428

Pharma Team 428

Chloramphenicol• Mechanism of action:

• Inhibits protein synthesis (50S subunit)

• Antibacterial activity, wide spectrum:

• H. Influenzae Salmonella typhi• N. Meningitidis E. coli• S. Pneumoniae V.cholera• Rickettsiae • Anaerobes-clostridium & B. fragilis

Page 19: PHARMA TEAM 428

Pharma Team 428

Page 20: PHARMA TEAM 428

Pharma Team 428

Cont’d

• PK:1. Rapidly & completely absorbed

from GIT.2. 30 % protein bound.3. Well distributed, including CNS

and CSF.4. Metabolized in the liver –

glucuronidation.5. Excreted in urine.

Page 21: PHARMA TEAM 428

Pharma Team 428

Cont’d

Page 22: PHARMA TEAM 428

Pharma Team 428

Clinical usageLimited because of potential toxicities (aplastic anemia 1:24,000 pts &

circulatory collapse in neonates)

1. Typhoid fever- S. typhi (quinolones are preferred)

2. Excellent drug against meningitis. H.influenzae, N.meningitidis, & S.pneumoniae. Conc in plasma to CSF 1:1.

( Ceftriaxone is the drug of choice for meningitis)

3. Anaerobic infections- B. fragilis (Metronidazole is the drug of choice) 4. Rickettsial infections – Doxycycline is

preferred5. Bacterial conjunctivitis (topical, no

side effect)

Page 23: PHARMA TEAM 428

Pharma Team 428

Cont’d• Side effects:1.Hypersensitivity- low incidence of hemolytic

anemia in G6PD deficient patients2. Aplastic anemia (rare but fatal)3.Gray-baby syndrome4.Superinfections5. Interaction with other drugs: Inhibits liver microsomal enzymes thus

there will be increase half-life of P450-dependent drugs:

Phenytoin Tolbutamide Chlorpropamide Oral Anticoagulants

Page 24: PHARMA TEAM 428

Pharma Team 428

Cont’d

Page 25: PHARMA TEAM 428

Pharma Team 428

Tetracyclines

Short acting

• Tetracycline• Oxytetracycline• t1/2: 6-8 hr

Intermediate

• Demeclocycline• Methacycline• t1/2: 12 hr

Long

• Doxycycline• Minocycline• t1/2: 16-18 hr

•Mechanism of action:1. Inhibition of protein synthesis by

binding reversibly to 30S subunit, bacteriostatic.

Page 26: PHARMA TEAM 428

Pharma Team 428

Cont’dAntibacterial activity:Broad spectrum antibiotics more

active against G +ve bacteria1. Chlamydia (approved by WHO)2. Rickettsiae 3. Brucella 4. Mycoplasma 5. H. pylori 6. V. cholera

Page 27: PHARMA TEAM 428

Pharma Team 428

Page 28: PHARMA TEAM 428

Pharma Team 428

Cont’d• PK1. Usually given orally2. Absorption adequate but incomplete

(except doxycycline & minocycline 90-100%)

3. Modifies intestinal flora because of its incomplete absorption.

4. Absorbed in the upper small intestine. Absorption is better in the absence of food

5. Food & di/trivalent cations: Ca, Mg, Fe, Al impair absorption

6. Protein binding 40-80 %

Page 29: PHARMA TEAM 428

Pharma Team 428

Cont’d

7. Distributed well, except to the CSF. Exception : minocycline,doxycycline penetrate BBB into the CSF

8. Cross the placenta and excreted in milk

9. Excretion: bile-10-40% (enterohepatic) and kidney-10-50%.

Exception : doxycycline is largely metabolized in the liver and excreted by GI. Thus, doesn’t require dose adjustment in renal failure.

Page 30: PHARMA TEAM 428

Pharma Team 428

Cont’d

Page 31: PHARMA TEAM 428

Pharma Team 428

Cont’d

Page 32: PHARMA TEAM 428

Pharma Team 428

Clinical usage1. Rickettsial infections – Drug of

choice2. Chlamydial infection – Drug of

choice3. Mycoplasma pneumonia – Drug of

choice (in adults only)4. Bacillary infections, Brucellosis in combination with

rifampin or streptomycin - Drug of choice

5. Cholera - Drug of choice

Page 33: PHARMA TEAM 428

Pharma Team 428

Cont’d6. Legionnaires’ disease (replaced

nowadays by azithromycin & ciprofloxacin)

7. Traveller’s diarrhea

8. H.pylori, in combination with bismuth & metronidazole or clarithromycin.

9. Miscellaneous – acne.

Page 34: PHARMA TEAM 428

Pharma Team 428

Cont’dSide effects:1. nausea, vomiting and diarrhea2. Thrombophlebitis – IV3. Phototoxicity (systemic administration) –

low incidence4. Hepatic toxicity (prolonged therapy with

high dose or pregnancy esp. after 4th month )

5. Kidney toxicity (duration & dose related), an important exception is doxycycline because it isn’t excreted in urine.

6. Brown discoloration of teeth in children

Page 35: PHARMA TEAM 428

Pharma Team 428

Cont’d

7. Deformity or growth inhibition of bones in children

8. Vertigo– minocycline 200-400 mg/d & doxycycline100 mg/d

9. Superinfections

Page 36: PHARMA TEAM 428

Pharma Team 428

Cont’d

Page 37: PHARMA TEAM 428

Pharma Team 428

• Pharma team 428 congrgulates you for finishing the antibiotics!

• Hope you enjoyed it!


Recommended